DVAX
NASDAQ · Biotechnology
Dynavax Technologies Corp
$15.50
+0.00 (+0.00%)
Open$15.49
Previous Close$15.50
Day High$15.50
Day Low$15.49
52W High$15.73
52W Low$9.20
Volume—
Avg Volume2.86M
Market Cap1.76B
P/E Ratio—
EPS$-0.38
SectorBiotechnology
Analyst Ratings
Strong Buy
9 analysts
Price Target
-10.3% upside
Current
$15.50
$15.50
Target
$13.91
$13.91
$9.87
$13.91 avg
$23.13
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 236.37M | 275.59M | 289.50M |
| Net Income | 23.28M | 24.43M | -60,500,728 |
| Profit Margin | 9.9% | 9.4% | -20.9% |
| EBITDA | 432.0K | 478.5K | -85,556,315 |
| Free Cash Flow | — | — | -57,246,430 |
| Rev Growth | -14.2% | -14.2% | -5.1% |
| Debt/Equity | 0.38 | 0.38 | 0.46 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $234.89 | +0.06% | 105.2 | 382.49B |
| AMGN | Amgen Inc | $351.43 | +1.27% | 23.4 | 182.21B |
| GILD | Gilead Sciences Inc | $125.16 | +0.09% | 16.7 | 153.66B |
| VRTX | Vertex Pharmaceuticals Inc | $475.20 | +1.45% | 26.4 | 114.63B |
| REGN | Regeneron Pharmaceuticals | $623.43 | +0.87% | 14.5 | 63.95B |
| ALNY | Alnylam Pharmaceuticals Inc | $294.06 | +2.04% | 64.3 | 37.13B |